Skip to Content
MilliporeSigma

Silver nitrate prophylaxis.

Canadian Medical Association journal (1984-08-01)
G Schneider
ABSTRACT

In many countries the statutory use of silver nitrate prophylaxis as soon as possible after birth has recently been reviewed from both a human rights and a medical standpoint. It has been argued that silver nitrate does not prevent all cases of gonococcal ophthalmia neonatorum (GON) and that it causes chemical conjunctivitis, pain and visual impairment, which may interfere with parent-infant bonding. Furthermore, the low incidence of GON, better methods of prenatal diagnosis, and the availability of suitable alternative prophylactic medication and of effective methods of treatment of GON have prompted recommendations that alternative prophylaxis be legally allowed or that mandatory prophylaxis be eliminated altogether. This paper reviews the situation and provides updated recommendations.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Silver standard solution, suitable for atomic absorption spectrometry, 1 mg/mL Ag, 1000 ppm Ag
Sigma-Aldrich
Silver nitrate, tested according to Ph. Eur.
Sigma-Aldrich
Silver nitrate, 99.9999% trace metals basis
Sigma-Aldrich
Silver nitrate, BioXtra, >99% (titration)
Sigma-Aldrich
Silver nitrate, BioReagent, suitable for plant cell culture, >99% (titration)
Sigma-Aldrich
Silver nitrate, meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
Silver nitrate, ReagentPlus®, ≥99.0% (titration)
Sigma-Aldrich
Silver nitrate, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8%
Sigma-Aldrich
Silver nitrate, puriss. p.a., ≥99.5% (AT)
Sigma-Aldrich
Silver nitrate, ACS reagent, ≥99.0%
Sigma-Aldrich
Silver nitrate solution, 0.05 M
Sigma-Aldrich
Silver nitrate solution, 0.0282 M
Sigma-Aldrich
Silver nitrate on silica gel, extent of labeling: ~10 wt. % loading, +230 mesh
Sigma-Aldrich
Silver nitrate solution, 2.5 % (w/v) AgNO3 in H2O